Artificial intelligence is transforming the medical device industry, offering unprecedented opportunities to enhance patient care. However, ...

Explore the evolving landscape of clinical trials in drug discovery and learn about recent breakthroughs transforming the ...

Creyon Bio, Inc. ("Creyon") today announced a global licensing and multi-target research collaboration with Eli Lilly and Company ("Lilly") focused on the discovery, development and commercialization ...

In 2025, pharmacy leaders are grappling with a billion-dollar question: how to deliver high-quality, patient-centered care amid financial strain, policy uncertainty, and rapid technological change.

Neurological disorders, including Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis, pose significant challenges due to their complex pathophysiology ...

Intellomx announces its' new Pilot platform, delivering rapid identification of novel drugs arising from its therapeutic ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

AI model reveals the structural secrets of misfolded proteins. A new artificial intelligence (AI) tool has provided critical ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level.

Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...

The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.